Hologic Inc. (HOLX) reported fourth-quarter net income of $34.9 million, or $0.13 per share, compared to a net loss of $144.4 million, or $0.56 per share, in the fourth quarter of fiscal 2008. Adjusted net income for the fourth quarter decreased to $72.44 million or $0.28 per share, from $77.2 million or $0.30 per share in the fourth quarter of fiscal 2008.
Fourth quarter fiscal 2009 revenues totaled $402.8 million, a decrease of 9.0% when compared to revenues of $442.5 million in the fourth quarter of fiscal 2008. The decrease was primarily attributable to the year-over-year decline in sales of Selenia systems.
Analysts polled by Thomson Reuters expected the company to report earnings of $0.27 per share on revenues of $398.27 million for the quarter. Analysts' estimates typically exclude special items.
The Board of Directors has promoted Robert Cascella to Chief Executive Officer. Cascella has served as President and Chief Operating Officer since 2003. Cascella has over 25 years of industry experience. Prior to joining Hologic, he was a managing partner of an investment banking firm specializing in healthcare and has held various executive management positions in the field of breast cancer diagnostics and therapeutics.
The Company expects first quarter fiscal 2010 revenues to be approximately $400 million to $405 million. The Company expects EPS to be approximately $0.06 to $0.08 and non-GAAP adjusted EPS to be approximately $0.24 to $0.26. Analysts expect the company to report earnings of $0.30 per share on revenues of $413.89 million for the first-quarter.
The Company expects fiscal 2010 revenues to be approximately $1.625 billion to $1.650 billion. The Company expects EPS to be approximately $0.42 to $0.46 and non-GAAP adjusted EPS to be approximately $1.15 to $1.19. Analysts expect the company to report earnings of $1.24 per share on revenues of $1.69 billion for fiscal 2010.
For comments and feedback: editorial@rttnews.com